WallStSmart
BBLG

Bone Biologics Corp

NASDAQ: BBLG · HEALTHCARE · BIOTECHNOLOGY

$1.31
-0.10% today

Updated 2026-06-05

Market cap
$2.30M
P/E ratio
P/S ratio
EPS (TTM)
$-1.16
Dividend yield
52W range
$1 – $7
Volume
0.0M

Bone Biologics Corp (BBLG) Financial statements

SEC filings — annual and quarterly data.

Cash flow — annual

Item200820092010201120122013201420152016201720182019202020212022202320242025
Operating cash flow$-24326.00$-4871.00$-45451.00$-5681.00$-447.00$-6116.00$-2.76M$-3.55M$-7.33M$-3.33M$-4.10M$-3.25M$-426933.00$-1.23M$-3.57M$-9.56M$-4.12M$-2.69M
Capital expenditures$0.00$0.00$0.00$0.00$0.00$0.00$11901.00$504.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$5.00$0.00
Depreciation
Stock-based comp$256642.00$3.70M$3.46M$-584027.00$516638.00$49692.00$60000.00$207035.00$266633.00$152599.00$188819.00$256358.00
Free cash flow$-24326.00$-4871.00$-45451.00$-5681.00$-447.00$-6116.00$-2.77M$-3.55M$-7.33M$-3.33M$-4.10M$-3.25M$-426933.00$-1.23M$-3.57M$-9.56M$-4.12M$-2.69M
Investing cash flow
Financing cash flow
Dividends paid$0.00$0.00$0.00$0.00$3.21M
Share repurchases
Debt repayment
Net change in cash$0.00$0.00$0.00$0.00$-24145.00

Frequently asked questions

How much free cash flow does BBLG generate?

BBLG produced $-2.69M in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.

Is BBLG's balance sheet healthy?

BBLG holds $5.33M in cash and equivalents against — in long-term debt, on $5.38M of shareholder equity. That debt is best read against the cash flow the business throws off each year.